Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
Diabetes Care
; 29(5): 1016-23, 2006 May.
Article
em En
| MEDLINE
| ID: mdl-16644631
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Oxazóis
/
Triglicerídeos
/
Glicemia
/
Tiazolidinedionas
/
Diabetes Mellitus Tipo 2
/
Glicina
/
HDL-Colesterol
/
Metformina
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article